Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05879159 · ClinicalTrials.gov registry record · NA
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
A NA study of Liver, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05879159: Recruiting NA study of Liver, sponsored by M.D. Anderson Cancer Center.
NCT05879159 is a NA study of Liver that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 36 participants, above the 14-participant average among 3 other Liver trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05879159, a NA study of Liver, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
What NCT05879159 shows while recruiting
NCT05879159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, above the 14-participant average among 3 other Liver trials with a reported enrollment target (157% higher).
The record links to 1 condition, with Liver appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT05879159 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05879159 about?
NCT05879159 is a clinical study titled "Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection". To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
What is the current status of trial NCT05879159?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-10-05. Estimated completion is 2027-02-01.
What conditions does trial NCT05879159 study?
This clinical trial studies the following conditions: Liver.
What interventions are being tested in trial NCT05879159?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05879159?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05879159 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
RECRUITING · NA
-
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI